In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 57 for your search:
Drug:  vinorelbine tartrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9509

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02725, ID99-303, U10CA045809, CDR0000067853, MDA-ID-99303, NCCAM, NCI-T99-0046, RTOG-0270, NCT00005838

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-9308

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000306463, GOG-0204, NCT00064077

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0347, S0347, NCT00103233

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00509, ECOG-E1505, CDR0000475774, E1505, U10CA180820, U10CA021115, SWOG-E1505, CALGB-E1505, CAN-NCIC-E1505, NCCTG-E1505, NCT00324805

7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000636895, CALGB-30506, NCT00863512

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: BR10, CAN-NCIC-BR10, CLB-9795, E-JBR10, SWOG-JBR10, GW-565/040, NCI-V94-0492, CDR0000063698, JBR10, NCT00002583

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: AHOD0831, NCI-2011-01994, CDR0000660550, U10CA098543, COG-AHOD0831, NCT01026220

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067324, P30CA016087, NYU-9712, NCI-G99-1596, NCT00004105

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000068042, CLB-59804, CALGB-59804, NCT00006029

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 01-088, MSKCC-01088A, NCI-G01-2025, NCT00026494

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 08103, P30CA033572, CHNMC-08103, BAYER-CHNMC-08103, CDR0000632806, NCI-2010-00924, NCT00828074

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 99L2, NCI-G99-1589, NCT00004096

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9532, CALGB-9532

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9431, CALGB-9431

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000064956, GOG-76Z, GOG-0076Z, NCT00002813

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: LAC-USC-4T961, NCI-G97-1174

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-127L, GOG-0127L

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: GOG-128E, GOG-0128E

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066106, COG-A09705, CCG-09705, NCT00003234

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000067163, P30CA016042, UCLA-9903029, NCI-G99-1545, NCT00003963

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 30 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: AHOD00P1, CCG-A5981, CDR0000068325, NCI-2012-02366, U10CA098543, COG-AHOD00P1, NCT00006760

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068398, NCCTG-N0022, N0022, NCT00008333

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000068575, S0102, U10CA032102, SWOG-S0102, NCT00015938
1    
New Search